fulvestrant has been researched along with Arrhythmia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eckardt, L; Ellermann, C; Frommeyer, G; Kirchner, LM; Leitz, PR; Rath, B; Willy, K; Wolfes, J | 1 |
| Chou, TF; Lee, TM; Su, SF; Tsai, CH | 1 |
2 other study(ies) available for fulvestrant and Arrhythmia
| Article | Year |
|---|---|
Electrophysiological Safety Profile of Antiestrogenic Therapies in the Isolated Rabbit Heart.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Fulvestrant; Heart; Rabbits; Tamoxifen | 2022 |
Differential effects of sarcolemmal and mitochondrial K(ATP) channels activated by 17 beta-estradiol on reperfusion arrhythmias and infarct sizes in canine hearts.
Topics: Acute Disease; Animals; Arrhythmias, Cardiac; Benzamides; Blood Pressure; Decanoic Acids; Dogs; Electrocardiography; Estradiol; Estrogen Antagonists; Fulvestrant; Hydroxy Acids; Male; Membrane Proteins; Mitochondria, Heart; Myocardial Infarction; Myocardial Reperfusion Injury; Potassium Channels; Sarcolemma; Ventricular Function, Left | 2002 |